ADVISORY/The Fourth Annual Conference on Regenerative Medicine to be Held November 17-19 in Washington, D.C.Business Editors/Health/Medical Writers ADVISORY...for November 17-19 (Mon-Wed) LARCHMONT, N.Y.--(BUSINESS WIRE)--Oct. 21, 2003 Leading researchers, scientists, physicians, and entrepreneurs in cell biology Cell biology The study of the activities, functions, properties, and structures of cells. Cells were discovered in the middle of the seventeenth century after the microscope was invented. , gene therapy, tissue engineering, therapeutic cloning therapeutic cloning n. A procedure in which damaged tissues or organs are repaired or replaced with genetically identical cells that originate from undifferentiated stem cells. and stem cells stem cells, unspecialized human or animal cells that can produce mature specialized body cells and at the same time replicate themselves. Embryonic stem cells are derived from a blastocyst (the blastula typical of placental mammals; see embryo), which is very young , and related fields will convene at the Renaissance Hotel in Washington, D.C., on November 17-19 to share the latest advances in the provocative new field of Regenerative re·gen·er·a·tive adj. 1. Of, relating to, or marked by regeneration. 2. Tending to regenerate. re·gen Medicine. Regenerative medicine is a unique new approach to healing that uses the body's own genes, proteins, antibodies, and cells to repair organs and tissues. Three days of meetings will include presentations and discussions of the newest research in stem cells, tissue engineering, bioethics bioethics, in philosophy, a branch of ethics concerned with issues surrounding health care and the biological sciences. These issues include the morality of abortion, euthanasia, in vitro fertilization, and organ transplants (see transplantation, medical). , cloning, nanobiotechnology, new ventures, and longevity, including innovations in biocompatible materials biocompatible material, n a substance that does not threaten, impede, or adversely affect living tissue. , bioinformatics, cell and stem cell stem cell In living organisms, an undifferentiated cell that can produce other cells that eventually make up specialized tissues and organs. There are two major types of stem cells, embryonic and adult. biology, embryology embryology Study of the formation and development of an embryo and fetus. Before widespread use of the microscope and the advent of cellular biology in the 19th century, embryology was based on descriptive and comparative studies. , gene therapy, genomics, organogenesis organogenesis /or·ga·no·gen·e·sis/ (or?gah-no-jen´e-sis) the origin and development of organs.organogenet´ic or·gan·o·gen·e·sis n. The formation and development of the organs of living things. , transplantation biology Transplantation biology The science of transferring a graft from one part of the body to another or from one individual to another. The graft may consist of an organ, tissue, or cells. If donor and recipient are the same individual, the graft is autologous. , and transplantation medicine.
What: The Fourth Annual Conference on Regenerative Medicine:
Rebuilding the Body, Restoring Function
When: November 17-19, 2003, opening Monday, Nov. 17 at 5:00
p.m.; concluding Wednesday, Nov. 19, at 5:00 p.m.
Where: Renaissance Washington, D.C., Hotel, 999 Ninth Street
N.W., Washington, D.C.
Who: Dr. William A. Haseltine, Chairman & CEO, Human Genome
Sciences, Inc., conference chair, will present opening
remarks and an overview November 17, at 5:00 p.m. on
Regenerative Medicine: Rebuilding the Body, Restoring
Function.
Dr. Robert S. Langer, Kenneth J. Germeshausen/Professor
of Chemical and Biomedical Engineering/MIT will present a
keynote address November 17, at 6:00 p.m. on Novel
Biomaterials.
Cellular Therapies: Repairing the Damaged and Worn Body--
Session Chair: Prof. Ian Wilmut, Roslin Institute
Exploring New Frontiers in Alzheimer's Disease - Session
Chair: Michael Wolfe, Ph.D., Associate Professor Center
for Neurologic Diseases/Brigham and Women's
Hospital/Harvard Medical School
Tissue Engineering - Supervisory Session Chair: Anthony
Atala, M.D., Director, Laboratory for Cellular
Therapeutics and Tissue Engineering/Professor of Surgery,
Children's Hospital Boston/ Harvard Medical School -
Session Chair: Robert M. Nerem, Ph.D., Director, Parker H.
Petit Institute for Bioengineering & Bioscience/Georgia
Institute of Technology
Substitutive Medicine: Organ Replacement and Repair -
Session Chair: Peer M. Portner, Ph.D., Consulting
Professor of Cardiothoracic Surgery/Stanford
University School of Medicine.
Sponsors: USF College of Medicine, Regenerative Medicine and
Stem Cell Biology www.mmsionline.com/regmed and Genetic
Engineering News www.genengnews.com.
Supporters: Human Genome Sciences, Inc., Therics, Inc. BioLife
Solutions.
Details: For complete program and registration, visit the web
site http://www.bioconferences.com/ebio.
Press Conference: Tuesday, November 18 at 10:30 a.m. in
Room 15
Contact: Limited press attendance; For press credentials,
please call or e-mail: BioConferences International, Inc.
Harriet I. Matysko, Senior Vice President 914-834-3100,
ext. 608; hmatysko@liebertpub.com
|
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion